behavior/neurological
• remain paralyzed at least 9 times longer than wild-type mice after treatment with zoxazolamine and no difference in the length of paralysis is seen with or without beta-naphthoflavone pretreatment
• in the absence of treatment no morphological or developmental abnormalities are detected
|